It has been reported that Beclin 1 inhibits apoptotic signaling in AML cells by enhancing Bcl‐xL binding to Beclin 1 and reducing Bad‐Bcl‐xL complex that promotes apoptosis [33]. The gene discussed is BCL2L1; the disease is acute myeloid leukemia.